Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAOB | P27338 | 1/20 | 0.75 |
| ▸ | CA1 | P00915 | 1/20 | 0.50 |
| ▸ | CA2 | P00918 | 1/20 | 0.50 |
| ▸ | ARG2 | P78540 | 1/20 | 0.50 |
| ▸ | AOC3 | Q16853 | 1/20 | 0.48 |
| ▸ | LOXL2 | Q9Y4K0 | 2/20 | 0.48 |
| ▸ | TOP1 | P11387 | 1/20 | 0.46 |
| ▸ | HTR2A | P28223 | 3/20 | 0.44 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.44 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.44 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.44 |
| ▸ | IDO1 | P14902 | 1/20 | 0.42 |
| ▸ | AGXT | P21549 | 1/20 | 0.41 |
| ▸ | KCNH2 | Q12809 | 2/20 | 0.40 |
| ▸ | MAOA | P21397 | 1/20 | 0.39 |
| ▸ | CALM1 | P0DP23 | 1/20 | 0.39 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6280201 | 1.00 | MAOB (0.75) | MAOBCA1CA2ARG2AOC3 | |
| Water SCHEMBL3478300 | 0.98 | MAOB (0.71) | MAOBCA1CA2ARG2AOC3 | |
| Hydrochloric Acid SCHEMBL5137799 | 0.98 | MAOB (0.71) | MAOBCA1CA2ARG2AOC3 | |
| SCHEMBL795584 | 0.93 | MAOB (0.65) | MAOBCA1CA2ARG2AOC3 | |
| SCHEMBL155055 | 0.87 | MAOB (1.00) | MAOBCA1CA2ARG2LOXL2 | |
| SCHEMBL1524697 | 0.87 | MAOB (1.00) | MAOBCA1CA2ARG2LOXL2 | |
| SCHEMBL155054 | 0.87 | MAOB (1.00) | MAOBCA1CA2ARG2LOXL2 | |
| SCHEMBL5489486 | 0.83 | MAOB (0.50) | MAOBCA1CA2ARG2AOC3 | |
| SCHEMBL5956337 | 0.81 | MAOB (0.68) | MAOBCA1CA2ARG2LOXL2 | |
| SCHEMBL3288071 | 0.78 | MAOB (0.62) | MAOBCA1CA2ARG2LOXL2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 241 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20180359854-A1 | POPULATION OF METAL OXIDE NANOSHEETS, PREPARATION METHOD THEREOF, AND ELECTRICAL CONDUCTOR AND ELECTRONIC DEVICE INCLUDING THE SAME | SAMSUNG ELECTRONICS CO LTD (KR) | 2018-12-13 | — | — | US | claimed |
| EP-1189622-B1 | ANIONIC POLYMERS AS TOXIN BINDERS AND ANTIBACTERIAL AGENTS | GENZYME CORP (US) | 2007-07-25 | — | — | EP | claimed |
| EP-1800687-A2 | Anionic polymers as toxin binders and antibacterial agents | GENZYME CORPORATION (US) | 2007-06-27 | — | — | EP | claimed |
| US-6890523-B2 | Anionic polymers as toxin binders and antibacterial agents | GENZYME CORPORATION (US) | 2005-05-10 | — | — | US | claimed |
| EP-1014999-B1 | CATIONIC POLYMERS AS TOXIN-BINDING AGENTS | GENZYME CORP (US) | 2004-12-08 | — | — | EP | claimed |
| US-20030138397-A1 | Anionic polymers as toxin binders and antibacterial agents | GELTEX PHARMACEUTICALS, INC. | 2003-07-24 | — | — | US | claimed |
| JP-2002544226-A | — | — | 2002-12-24 | — | — | JP | claimed |
| EP-1189622-A2 | ANIONIC POLYMERS AS TOXIN BINDERS AND ANTIBACTERIAL AGENTS | Geltex Pharmaceuticals, Inc. (US) | 2002-03-27 | — | — | EP | claimed |
| US-20010041171-A1 | Anionic polymers as toxin binders | GELTEX PHARMACEUTICALS, INC. (US) | 2001-11-15 | — | — | US | claimed |
| US-6270755-B1 | POLYMER COMPRISING PENDANT ACID FUNCTIONAL GROUPS OR A SALT THEREOF WITH A PHARMACEUTICALLY ACCEPTABLE CATION, SAID POLYMER COMPRISING NO ACID ANHYDRIDE GROUPS. | GELTEX PHARMACEUTICALS, INC. | 2001-08-07 | — | — | US | claimed |
| WO-1999015186-A1 | CATIONIC POLYMERS AS TOXIN-BINDING AGENTS | GELTEX PHARMACEUTICALS, INC. (US) | 1999-04-01 | — | — | WO | claimed |
| US-5411845-A | Coatings for light sensitive photographic film elements | IMPERIAL CHEMICAL INDUSTRIES PLC (GB) | 1995-05-02 | — | — | US | claimed |
| EP-0277894-B1 | PROCESS FOR THE PREPARATION OF TRIALKOXYBENZALDEHYDE | RHONE-POULENC CHIMIE (FR) | 1992-01-29 | — | — | EP | claimed |
| US-4933498-A | HYDROLYZING BROMO-HYDROXY-METHOXY BENZALDEHYDE, DIRECTLY ETHERIFYING WITH A LOWER ALKYL HALIDE | RHONE-POULENC CHIMIE (FR) | 1990-06-12 | — | — | US | claimed |
| EP-0277894-A2 | Process for the preparation of trialkoxybenzaldehyde | RHONE-POULENC CHIMIE (FR) | 1988-08-10 | — | — | EP | claimed |
| US-4754089-A | SEPARATION OF PHASE BY PERMEABLE MEMBRANE | SEPRACOR INC. (US) | 1988-06-28 | — | — | US | claimed |
| US-4644042-A | USING WATER SOLUBLE FREE RADICAL POLYMERIZATION CATALYST | NITTO BOSEKI CO., LTD. (JP) | 1987-02-17 | — | — | US | claimed |
| EP-0173963-A2 | Polymers of n-substituted secondary monoallylamines and their salts and process for producing the same | NITTO BOSEKI CO., LTD. (JP) | 1986-03-12 | — | — | EP | claimed |
| EP-0066103-B1 | PROCESS FOR THE REDUCTION OF REDUCIBLE GROUPS, AND ITS APPLICATION | Eckert, Heiner, dr. (DE) | 1985-08-28 | — | — | EP | claimed |
| US-4299911-A | POLYMER CONTAINING AN ETHYLENICALLY UNSATURATED DOUBLE BOND | SOMAR MANUFACTURING CO., LTD. (JP) | 1981-11-10 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20010041171-A1 | Anionic polymers as toxin binders | PIGS, CD47, BTD | MAOB 2782/4885CA1 748/4885CA2 1578/4885 |
| US-20030138397-A1 | Anionic polymers as toxin binders and antibacterial agents | MSN, ANTXR2, PNKP | MAOB 2903/4885CA1 2335/4885CA2 2499/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.